Wen Xie, the Joseph Koslow Endowed Chair in Pharmaceutical Sciences, Professor of Pharmaceutical Sciences and Director of the Center for Pharmacogenetics, has been awarded with a new 5-year NIH R01 grant titled “The perinatal Pharmacology of the Nuclear Receptor FXR.” The funding period is 04/01/13 – 03/31/18. The grant is funded through the National Institute of Child Health and Human Development (NICHD).
Wen Xie, the Joseph Koslow Endowed Chair in Pharmaceutical Sciences, Professor of Pharmaceutical Sciences and Director of the Center for Pharmacogenetics, has been awarded with a new 5-year NIH R01 grant titled “The perinatal Pharmacology of the Nuclear Receptor FXR.” The funding period is 04/01/13 – 03/31/18. The grant is funded through the National Institute of Child Health and Human Development (NICHD).
